General Information of the Compound
Compound ID |
CP0478019
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(S)-2-((3S,4S)-3-((S)-2-((S)-1-((S)-2-((S)-2-amino-5-guanidinopentanamido)-5-guanidinopentanoyl)pyrrolidine-2-carboxamido)-3-(4-hydroxyphenyl)propanamido)-4-methylhexanamido)-4-methylpentanoic acid
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C39H66N12O8
|
||||||||||||||||||
Molecular Weight |
831.033
|
||||||||||||||||||
Canonical SMILES |
CC[C@H](C)[C@H](CC(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCCN=C(N)N
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C39H66N12O8/c1-5-23(4)28(21-32(53)47-30(37(58)59)19-22(2)3)49-34(55)29(20-24-12-14-25(52)15-13-24)50-35(56)31-11-8-18-51(31)36(57)27(10-7-17-46-39(43)44)48-33(54)26(40)9-6-16-45-38(41)42/h12-15,22-23,26-31,52H,5-11,16-21,40H2,1-4H3,(H,47,53)(H,48,54)(H,49,55)(H,50,56)(H,58,59)(H4,41,42,45)(H4,43,44,46)/t23-,26-,27-,28-,29-,30-,31-/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
SFVVNSFJBCCOAB-VGPFALITSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02429, Neurotensin receptor type 1
Protein ID: PT02626, Neurotensin receptor type 2